Literature DB >> 11052913

Deletion of the putative antioxidant noxR1 does not alter the virulence of Mycobacterium tuberculosis H37Rv.

G R Stewart1, S Ehrt, L W Riley, J W Dale, J McFadden.   

Abstract

SETTING: The cloned M. tuberculosis noxR1 gene has been shown to confer resistance to reactive nitrogen intermediates (RNI) and reactive oxygen intermediates (ROI) upon Escherichia coli and Mycobacterium smegmatis.
OBJECTIVE: To investigate the role of noxR1 in resistance to RNI and virulence of M. tuberculosis.
DESIGN: The noxR1 gene was deleted from M. bovis BCG and M. tuberculosis H37Rv by allelic exchange. The mutants were compared to wild type strains with respect to resistance to chemically generated RNI. The virulence of the M. tuberculosis mutant was investigated in a murine model of infection.
RESULTS: The NoxR1 mutants grew normally in Sautons and 7H9 broths. The BCG mutant demonstrated decreased resistance to in vitro generated RNI compared to the wild type. Resistance to RNI could be restored to the mutant by reintroduction of the noxR1 locus on a replicating plasmid. However, deletion of noxR1 from M. tuberculosis H37Rv did not result in decreased resistance to RNI nor a difference in growth and survival of the bacterium during murine infection.
CONCLUSION: The noxR1 gene locus in M. bovis BCG bestows ability to resist RNI generated in vitro. In M. tuberculosis H37Rv, however, noxR1 is either not involved in RNI resistance and virulence or is better compensated for by other mechanisms. 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11052913     DOI: 10.1054/tuld.2000.0251

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  2 in total

1.  Dihydrolipoamide acyltransferase is critical for Mycobacterium tuberculosis pathogenesis.

Authors:  Shuangping Shi; Sabine Ehrt
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  A mutant of Mycobacterium tuberculosis H37Rv that lacks expression of antigen 85A is attenuated in mice but retains vaccinogenic potential.

Authors:  Robert H Copenhaver; Eliud Sepulveda; Lisa Y Armitige; Jeffrey K Actor; Audrey Wanger; Steven J Norris; Robert L Hunter; Chinnaswamy Jagannath
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.